Sign Up to like & get
recommendations!
2
Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0284708
Abstract: Hodgkin’s lymphoma and anaplastic large cell lymphoma, especially relapsed or refractory diseases, could recently be cured by CD30-targeted immunotherapy. However, the CD30 antigen releases the soluble ectodomain of CD30, which might obscure the targeted therapy.…
read more here.
Keywords:
targeted immunotherapy;
cd30;
huscfv;
single chain ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Iranian Journal of Biotechnology"
DOI: 10.30498/ijb.2020.138200.2314
Abstract: Background: Overexpression of EGFR is associated with carcinogenesis in more than 70% of head and neck cancers. Anti-EGFR monoclonal antibodies bind to the extracellular domain of EGFR and block the EGFR downstream signaling pathway, which…
read more here.
Keywords:
expression;
huscfv;
escherichia coli;
egfr ... See more keywords